Quorum Health Corporation Appoints Three Members to Board of Directors
September 10 2018 - 8:00AM
Business Wire
Quorum Health Corporation (NYSE: QHC) announced today that its
Board of Directors has appointed Jon H. Kaplan and William Paul
Rutledge as independent, non-employee directors. In addition, the
Company announced that Robert H. Fish, the Company’s President and
Chief Executive Officer, has also been appointed to the Board of
Directors. These appointments are effective immediately and expand
the composition of the Board to nine members.
“We are pleased to welcome Mr. Kaplan, Mr. Rutledge and Mr.
Fish, all of whom bring a wealth of both hospital and broader
healthcare industry experience, to our Board of Directors. Their
expertise will be invaluable to Quorum Health’s board as we
continue to execute on the Company’s strategic initiatives,” said
Terry Allison Rappuhn, Chair of Quorum Health’s Board of
Directors.
Mr. Kaplan, 51, has extensive business experience consulting and
advising healthcare companies. Since 2007, he has served as a
Senior Partner and Managing Director of the Boston Consulting
Group, Inc. (“BCG”) a privately-held company focused on providing
management consulting services, where he recently served on BCG’s
global leadership council and as the practice leader of BCG’s
healthcare services. Previously, Mr. Kaplan was a partner in the
consulting division of Ernst & Young, where he served for over
ten years. Mr. Kaplan received a B.A. in Economics from Cornell
University, a Masters of Public Health from the University of
Pittsburgh and an M.B.A. from the Kellogg Graduate School of
Management at Northwestern University. Mr. Kaplan brings to the
Board valuable experience from his roles consulting and advising
healthcare companies.
Mr. Rutledge, 63, has over 40 years of experience in the health
care industry and currently serves as an advisor and board member
to healthcare companies. Since October 2017, Mr. Rutledge has
served on the board of directors for portfolio companies of Shore
Capital Partners, LLC, a healthcare-focused private equity firm,
and since 2014, he has served on the advisory board of Clayton
Associates, a healthcare-focused venture capital fund. He served as
CEO of Chinaco Healthcare Corporation from January 2016 through
completion of its sale to an Asian private equity fund in April
2017. Previously, Mr. Rutledge spent approximately thirty years of
his career at HCA Healthcare, Inc. (NYSE: HCA), most recently
serving as the President of the HCA Central Group from October 2005
through March 2013. He has also served as a director of the
American Hospital Association, the Tennessee Hospital Association,
and the Federation of American Hospitals. Mr. Rutledge earned a
B.S. from the University of Georgia and a Masters of Health
Administration from Georgia State University. Mr. Rutledge brings
to the Board valuable experience from his director and senior
management roles at other healthcare companies, as well as his
extensive knowledge of the hospital industry.
About Quorum Health Corporation
Quorum Health Corporation is an operator of general acute care
hospitals and outpatient services in the United States. Through its
subsidiaries, the Company owns, leases or operates a diversified
portfolio of 28 affiliated hospitals in rural and mid-sized markets
located across 14 states with an aggregate of 2,649 licensed beds.
The Company also operates Quorum Health Resources, LLC, a leading
hospital management advisory and consulting services business. More
information about Quorum Health Corporation can be found at
www.quorumhealth.com.
Forward-Looking Statements
Statements contained in this news release regarding expected
operating results, acquisition transactions or divestitures and
other events are forward-looking statements that involve risk and
uncertainties. Actual future events or results may differ
materially from these statements. Readers are referred to the
documents filed by Quorum Health Corporation with the Securities
and Exchange Commission, including the Company’s annual report on
Form 10-K, current reports on Form 8-K and quarterly reports on
Form 10-Q. These filings identify important risk factors and other
uncertainties that could cause actual results to differ from those
contained in the forward-looking statements. The Company undertakes
no obligation to revise or update any forward-looking statements,
or to make any other forward-looking statements, whether as a
result of new information, future events or otherwise.
The terms “QHC,” “Quorum Health,” “the Company,” “we,” “us” or
“our” refer to Quorum Health Corporation or one or more of its
subsidiaries or affiliates as applicable.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20180910005231/en/
For Quorum Health CorporationInvestors:Alfred Lumsdaine,
615-371-4936Executive Vice President and Chief Financial
Officer
Quorum Health (NYSE:QHC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Quorum Health (NYSE:QHC)
Historical Stock Chart
From Apr 2023 to Apr 2024